Dag Hoem

2.1k total citations · 1 hit paper
37 papers, 1.6k citations indexed

About

Dag Hoem is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Dag Hoem has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 21 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Dag Hoem's work include Pancreatic and Hepatic Oncology Research (20 papers), Pancreatic function and diabetes (11 papers) and Neuroendocrine Tumor Research Advances (6 papers). Dag Hoem is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Pancreatic function and diabetes (11 papers) and Neuroendocrine Tumor Research Advances (6 papers). Dag Hoem collaborates with scholars based in Norway, United States and Sweden. Dag Hoem's co-authors include Anders Molven, Georg Dimcevski, Odd Helge Gilja, Heike Immervoll, Michiel Postema, Spiros Kotopoulis, Asgaut Viste, Åke Andrén‐Sandberg, Halfdan Sørbye and Per Øystein Sakariassen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Diabetes.

In The Last Decade

Dag Hoem

37 papers receiving 1.6k citations

Hit Papers

A human clinical trial using ultrasound and microbubbles ... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dag Hoem Norway 20 701 621 504 300 268 37 1.6k
Takao Matsubara Japan 24 467 0.7× 284 0.5× 395 0.8× 861 2.9× 348 1.3× 81 1.7k
Quirijn R.J.G. Tummers Netherlands 20 337 0.5× 425 0.7× 583 1.2× 431 1.4× 163 0.6× 26 1.5k
Alan G. Wile United States 20 460 0.7× 344 0.6× 281 0.6× 841 2.8× 197 0.7× 50 1.4k
Yasutoshi Murayama Japan 22 513 0.7× 616 1.0× 331 0.7× 876 2.9× 205 0.8× 158 1.6k
L. Tomio Italy 19 452 0.6× 665 1.1× 231 0.5× 719 2.4× 219 0.8× 50 1.6k
Yoshiaki Kuriu Japan 25 827 1.2× 1.1k 1.9× 256 0.5× 1.0k 3.4× 390 1.5× 210 2.4k
Atsushi Kurabayashi Japan 18 178 0.3× 250 0.4× 243 0.5× 369 1.2× 281 1.0× 56 951
Luo‐Wei Wang China 15 318 0.5× 403 0.6× 248 0.5× 416 1.4× 223 0.8× 58 944
Gianpaolo Vidili Italy 14 212 0.3× 340 0.5× 153 0.3× 152 0.5× 146 0.5× 29 970
Kunihiro Asanuma Japan 21 479 0.7× 332 0.5× 151 0.3× 587 2.0× 187 0.7× 115 1.4k

Countries citing papers authored by Dag Hoem

Since Specialization
Citations

This map shows the geographic impact of Dag Hoem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Hoem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Hoem more than expected).

Fields of papers citing papers by Dag Hoem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dag Hoem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Hoem. The network helps show where Dag Hoem may publish in the future.

Co-authorship network of co-authors of Dag Hoem

This figure shows the co-authorship network connecting the top 25 collaborators of Dag Hoem. A scholar is included among the top collaborators of Dag Hoem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dag Hoem. Dag Hoem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johansson, Bente B., Karianne Fjeld, Aristotelis Antonopoulos, et al.. (2018). The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants. Journal of Biological Chemistry. 293(50). 19476–19491. 12 indexed citations
3.
Patti, Mary‐Elizabeth, Allison B. Goldfine, Jiang Hu, et al.. (2017). Heterogeneity of proliferative markers in pancreatic β-cells of patients with severe hypoglycemia following Roux-en-Y gastric bypass. Acta Diabetologica. 54(8). 737–747. 14 indexed citations
4.
Hoem, Dag, May Britt Kalvenes, Solrun J. Steine, et al.. (2017). Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival. Cancer Medicine. 6(7). 1531–1540. 26 indexed citations
5.
Berle, Magnus, et al.. (2017). Indre tarmbrokk. Tidsskrift for Den norske legeforening. 137(16). 4 indexed citations
6.
Dimcevski, Georg, Spiros Kotopoulis, Tormod Bjånes, et al.. (2016). A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Journal of Controlled Release. 243. 172–181. 359 indexed citations breakdown →
7.
Viste, Asgaut, et al.. (2015). Percutaneous cholecystostomy in acute cholecystitis; a retrospective analysis of a large series of 104 patients. BMC Surgery. 15(1). 17–17. 42 indexed citations
8.
Angelsen, Jon‐Helge, Asgaut Viste, Inger Marie Løes, et al.. (2015). Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. World Journal of Surgical Oncology. 13(1). 328–328. 23 indexed citations
9.
Viste, Asgaut, et al.. (2015). Bile duct injuries following laparoscopic cholecystectomy. Scandinavian Journal of Surgery. 104(4). 233–237. 25 indexed citations
10.
Erchinger, Friedemann, Trond Engjom, Erling Tjora, et al.. (2013). Quantification of Pancreatic Function Using a Clinically Feasible Short Endoscopic Secretin Test. Pancreas. 42(7). 1101–1106. 28 indexed citations
11.
Kotopoulis, Spiros, Georg Dimcevski, Odd Helge Gilja, Dag Hoem, & Michiel Postema. (2013). Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: A clinical case study. Medical Physics. 40(7). 72902–72902. 184 indexed citations
12.
Hoem, Dag & Asgaut Viste. (2012). Improving survival following surgery for pancreatic ductal adenocarcinoma – A ten-year experience. European Journal of Surgical Oncology. 38(3). 245–251. 23 indexed citations
13.
Johansson, Bente B., Janniche Torsvik, Lise Bjørkhaug, et al.. (2011). Diabetes and Pancreatic Exocrine Dysfunction Due to Mutations in the Carboxyl Ester Lipase Gene-Maturity Onset Diabetes of the Young (CEL-MODY). Journal of Biological Chemistry. 286(40). 34593–34605. 74 indexed citations
14.
Immervoll, Heike, et al.. (2008). Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer. 8(1). 48–48. 175 indexed citations
15.
Sandberg, A. A., et al.. (2007). Epidemiology and risk factors for exocrine pancreatic cancer. Annals of Gastroenterology. 13(3). 4 indexed citations
16.
Immervoll, Heike, et al.. (2006). Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(6). 788–796. 78 indexed citations
17.
Hoem, Dag, et al.. (2002). Influence of Laparoscopic Cholecystectomy on the Prevalence of Operations for Gallstones in Norway. The European Journal of Surgery. 168(8). 464–469. 13 indexed citations
18.
Andrén‐Sandberg, Åke, Dag Hoem, & Hjörtur Gíslason. (2002). Pain management in chronic pancreatitis. European Journal of Gastroenterology & Hepatology. 14(9). 957–970. 74 indexed citations
19.
Hoem, Dag, et al.. (2002). Nonadhesive Organ Culture of Human Exocrine Pancreatic Cells with Their Stroma. Pancreas. 25(1). 71–77. 17 indexed citations
20.
Andrén‐Sandberg, Åke, Asgaut Viste, Arild Horn, Dag Hoem, & Hjörtur Gíslason. (1999). Pain management of pancreatic cancer. Annals of Oncology. 10. S265–S268. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026